- The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma
-
Lee MMP, Chan LL, Chan SL
- KMID: 2546408
- J Liver Cancer.
- 2023 Sep;23(2):262-271.
- doi: 10.17998/jlc.2023.07.17
Hepatocellular carcinoma (HCC) frequently presents as advanced stage with poor prognosis and high mortality. Systemic treatment is the treatment of choice for advanced disease. In 2007, the first multi-kinase inhibitor... -
- CITED
-
- Close
- SHARE
-
- Close
